Literature DB >> 24999042

HIV replication in conjunction with granzyme B production by CCR5+ memory CD4 T cells: Implications for bystander cell and tissue pathologies.

Jacob Couturier1, Alexander T Hutchison1, Miguel A Medina1, Cosmina Gingaras2, Petri Urvil3, Xiaoying Yu2, Chi Nguyen2, Parag Mahale1, Lin Lin1, Claudia A Kozinetz2, Joern E Schmitz4, Jason T Kimata5, Tor C Savidge3, Dorothy E Lewis6.   

Abstract

Granzyme B (GrzB) is expressed by activated T cells and mediates cellular apoptosis. GrzB also acts as an extracellular protease involved in tissue degradation. We hypothesized that GrzB production from activated memory CD4 T cells may be associated with HIV pathogenesis. We found that stimulated memory CD4 T cells (via costimulation, cytokines, and TLR ligands) concomitantly produced GrzB and HIV. Both GrzB and HIV expression were mainly restricted to CCR5-expressing memory CD4+CD45RO+ T cells, including Th1 and Th17 subsets. Activated memory CD4 T cells also mediated tissue damage, such as disruption of intestinal epithelial monolayers. In non-human primates, CD4 T cells of rhesus macaques (pathogenic SIV hosts) expressed higher GrzB compared to African green monkeys (non-pathogenic SIV hosts). These results suggest that GrzB from CCR5+ memory CD4 T cells may have a role in cellular and tissue pathologies during HIV infection.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  CCR5; Enteropathy; Granzyme B; HIV replication; Memory CD4 T cells; SIV pathogenesis

Mesh:

Substances:

Year:  2014        PMID: 24999042      PMCID: PMC4158656          DOI: 10.1016/j.virol.2014.06.008

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  58 in total

1.  Expression of the chemokine receptors CCR4, CCR5, and CXCR3 by human tissue-infiltrating lymphocytes.

Authors:  Eric J Kunkel; Judie Boisvert; Kristine Murphy; Mark A Vierra; Mark C Genovese; Andrew J Wardlaw; Harry B Greenberg; Martin R Hodge; Lijun Wu; Eugene C Butcher; James J Campbell
Journal:  Am J Pathol       Date:  2002-01       Impact factor: 4.307

Review 2.  Cytolytic CD4 cells: Direct mediators in infectious disease and malignancy.

Authors:  Deborah M Brown
Journal:  Cell Immunol       Date:  2010-02-24       Impact factor: 4.868

3.  Tumor necrosis factor alpha increases epithelial barrier permeability by disrupting tight junctions in Caco-2 cells.

Authors:  W Cui; L X Li; C M Sun; Y Wen; Y Zhou; Y L Dong; P Liu
Journal:  Braz J Med Biol Res       Date:  2010-03-19       Impact factor: 2.590

4.  HIV virions and HIV infection in vitro are unaffected by human granzymes A and B.

Authors:  C E Mackewicz; J Lieberman; C Froelich; J A Levy
Journal:  AIDS Res Hum Retroviruses       Date:  2000-03-01       Impact factor: 2.205

5.  Disruption of intestinal CD4+ T cell homeostasis is a key marker of systemic CD4+ T cell activation in HIV-infected individuals.

Authors:  Shari N Gordon; Barbara Cervasi; Pamela Odorizzi; Randee Silverman; Faten Aberra; Gregory Ginsberg; Jacob D Estes; Mirko Paiardini; Ian Frank; Guido Silvestri
Journal:  J Immunol       Date:  2010-10-01       Impact factor: 5.422

6.  Exposure to HIV-1 directly impairs mucosal epithelial barrier integrity allowing microbial translocation.

Authors:  Aisha Nazli; Olivia Chan; Wendy N Dobson-Belaire; Michel Ouellet; Michel J Tremblay; Scott D Gray-Owen; A Larry Arsenault; Charu Kaushic
Journal:  PLoS Pathog       Date:  2010-04-08       Impact factor: 6.823

7.  Tumor-reactive CD4(+) T cells develop cytotoxic activity and eradicate large established melanoma after transfer into lymphopenic hosts.

Authors:  Sergio A Quezada; Tyler R Simpson; Karl S Peggs; Taha Merghoub; Jelena Vider; Xiaozhou Fan; Ronald Blasberg; Hideo Yagita; Pawel Muranski; Paul A Antony; Nicholas P Restifo; James P Allison
Journal:  J Exp Med       Date:  2010-02-15       Impact factor: 14.307

8.  Contrasting roles for TLR ligands in HIV-1 pathogenesis.

Authors:  Beda Brichacek; Christophe Vanpouille; Yana Kiselyeva; Angelique Biancotto; Melanie Merbah; Ivan Hirsch; Andrea Lisco; Jean Charles Grivel; Leonid Margolis
Journal:  PLoS One       Date:  2010-09-20       Impact factor: 3.240

9.  Cutting Edge: Responder T cells regulate human DR+ effector regulatory T cell activity via granzyme B.

Authors:  Charles W Ashley; Clare Baecher-Allan
Journal:  J Immunol       Date:  2009-10-15       Impact factor: 5.422

Review 10.  Intracellular versus extracellular granzyme B in immunity and disease: challenging the dogma.

Authors:  Wendy Anne Boivin; Dawn Michelle Cooper; Paul Ryan Hiebert; David James Granville
Journal:  Lab Invest       Date:  2009-09-21       Impact factor: 5.502

View more
  9 in total

1.  Intestinal CD4 Depletion in HIV / SIV Infection.

Authors:  Ronald S Veazey
Journal:  Curr Immunol Rev       Date:  2019

Review 2.  Cytotoxic CD4 T Cells-Friend or Foe during Viral Infection?

Authors:  Jennifer A Juno; David van Bockel; Stephen J Kent; Anthony D Kelleher; John J Zaunders; C Mee Ling Munier
Journal:  Front Immunol       Date:  2017-01-23       Impact factor: 7.561

3.  Evaluation of HIV-specific T-cell responses in HIV-infected older patients with controlled viremia on long-term antiretroviral therapy.

Authors:  Nicole E Behrens; Anne Wertheimer; Maria B Love; Stephen A Klotz; Nafees Ahmad
Journal:  PLoS One       Date:  2020-09-17       Impact factor: 3.240

4.  Granzyme B+ CD4 T cells accumulate in the colon during chronic HIV-1 infection.

Authors:  Stephanie M Dillon; Kaylee L Mickens; Tezha A Thompson; Emily H Cooper; Sabrina Nesladek; Allison J Christians; Moriah Castleman; Kejun Guo; Cheyret Wood; Daniel N Frank; Katerina Kechris; Mario L Santiago; Cara C Wilson
Journal:  Gut Microbes       Date:  2022 Jan-Dec

5.  Granzyme B secretion by human memory CD4 T cells is less strictly regulated compared to memory CD8 T cells.

Authors:  Lin Lin; Jacob Couturier; Xiaoying Yu; Miguel A Medina; Claudia A Kozinetz; Dorothy E Lewis
Journal:  BMC Immunol       Date:  2014-09-24       Impact factor: 3.615

6.  Multilineage polyclonal engraftment of Cal-1 gene-modified cells and in vivo selection after SHIV infection in a nonhuman primate model of AIDS.

Authors:  Christopher W Peterson; Kevin G Haworth; Bryan P Burke; Patricia Polacino; Krystin K Norman; Jennifer E Adair; Shiu-Lok Hu; Jeffrey S Bartlett; Geoff P Symonds; Hans-Peter Kiem
Journal:  Mol Ther Methods Clin Dev       Date:  2016-02-24       Impact factor: 6.698

7.  The transcription factors Runx3 and ThPOK cross-regulate acquisition of cytotoxic function by human Th1 lymphocytes.

Authors:  Yasmina Serroukh; Chunyan Gu-Trantien; Baharak Hooshiar Kashani; Matthieu Defrance; Thien-Phong Vu Manh; Abdulkader Azouz; Aurélie Detavernier; Alice Hoyois; Jishnu Das; Martin Bizet; Emeline Pollet; Tressy Tabbuso; Emilie Calonne; Klaas van Gisbergen; Marc Dalod; François Fuks; Stanislas Goriely; Arnaud Marchant
Journal:  Elife       Date:  2018-02-28       Impact factor: 8.140

8.  Nicotinamide combined with gemcitabine is an immunomodulatory therapy that restrains pancreatic cancer in mice.

Authors:  Benson Chellakkan Selvanesan; Kiran Meena; Amanda Beck; Lydie Meheus; Olaya Lara; Ilse Rooman; Claudia Gravekamp
Journal:  J Immunother Cancer       Date:  2020-11       Impact factor: 13.751

9.  Screening and identification of key regulatory connections and immune cell infiltration characteristics for lung transplant rejection using mucosal biopsies.

Authors:  Meng-Xi Xiu; Zu-Ting Liu; Jian Tang
Journal:  Int Immunopharmacol       Date:  2020-08-10       Impact factor: 4.932

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.